Suppr超能文献

评估自动化Wes系统作为支持单克隆抗体药物产品开发的分析和表征工具。

Evaluation of automated Wes system as an analytical and characterization tool to support monoclonal antibody drug product development.

作者信息

Wang Jinyu, Valdez Anulfo, Chen Yingchen

机构信息

Biologics Manufacturing and Process Development (BMPD), Bristol-Myers Squibb, 519 Route 173, Bloomsbury, NJ 08804, USA.

Biologics Manufacturing and Process Development (BMPD), Bristol-Myers Squibb, 519 Route 173, Bloomsbury, NJ 08804, USA.

出版信息

J Pharm Biomed Anal. 2017 May 30;139:263-268. doi: 10.1016/j.jpba.2016.12.024. Epub 2016 Dec 21.

Abstract

Monitoring and evaluation of critical quality attributes (cQA) in monoclonal antibodies (mAb) are a regulatory requirement in pharmaceutical industry. High molecular weight (HMW) species are of critical importance due to the potential risk associated with immunogenicity. HMW species are typically monitored by size exclusion chromatography (SEC). Although low molecular weight (LMW) species are also detected by SEC, low-resolution separation of LMW limits its capability to monitor mAb fragmentation. Recently, we have developed new methods for LMW characterization and evaluation based on the Wes instrument from ProteinSimple. The capillary western blot is based upon size-based separation in a capillary system, and detection by specific immunoprobing, following the separation. The capability of this method for characterization of mAb fragments were demonstrated. The characterization was achieved by probing two antibodies targeted to specific regions (Fc region or Fab region) of IgG1 protein. The specificity of these two antibodies was evaluated against F (ab') 2 and Fc/2 fragments generated from Ides enzyme treated IgG1 protein. The results showed the selected antibodies provide high specificity to F (ab') 2 and Fc/2 fragments. Fractions collected from SEC were used to evaluate this method. The detected fragments from SEC fractions were identified based on their estimated molecular weight and antibody detection. The result proved the capability of the capillary western blot as a characterization method for IgG1 fragments. In addition, with the specific detection to IgG1 and IgG4, the power of the capillary western blot to specifically characterize and evaluate individual IgG fragmentations in an IgG1 and IgG4 mixture was also demonstrated. When heat stressed samples were used, results showed method capability as stability indicating in IgG1 and IgG4 mixture samples. The stressed mixture samples were also evaluated by the total protein assay in which protein samples were biotinylated after separation and were labeled with HRP linked streptavidin to provide chemiluminescence detection. The results indicated total protein assay can be a useful complementary method to capillary western blot immunoassay.

摘要

监测和评估单克隆抗体(mAb)中的关键质量属性(cQA)是制药行业的一项监管要求。由于与免疫原性相关的潜在风险,高分子量(HMW)物质至关重要。HMW物质通常通过尺寸排阻色谱法(SEC)进行监测。虽然SEC也能检测到低分子量(LMW)物质,但LMW的低分辨率分离限制了其监测mAb片段化的能力。最近,我们基于ProteinSimple公司的Wes仪器开发了用于LMW表征和评估的新方法。毛细管western印迹法基于毛细管系统中的尺寸分离,并在分离后通过特异性免疫探针检测。证明了该方法用于表征mAb片段的能力。通过探测靶向IgG1蛋白特定区域(Fc区域或Fab区域)的两种抗体来实现表征。评估了这两种抗体针对由Ides酶处理的IgG1蛋白产生的F(ab')2和Fc/2片段的特异性。结果表明,所选抗体对F(ab')2和Fc/2片段具有高特异性。使用从SEC收集的馏分来评估该方法。根据SEC馏分中检测到的片段的估计分子量和抗体检测来鉴定它们。结果证明了毛细管western印迹法作为IgG1片段表征方法的能力。此外,通过对IgG1和IgG4的特异性检测,还证明了毛细管western印迹法在特异性表征和评估IgG1和IgG4混合物中单个IgG片段化方面的能力。当使用热应激样品时,结果表明该方法能够作为IgG1和IgG4混合物样品的稳定性指示方法。还通过总蛋白测定法对应激混合物样品进行了评估,其中蛋白质样品在分离后进行生物素化,并用HRP连接的链霉亲和素进行标记以提供化学发光检测。结果表明,总蛋白测定法可以作为毛细管western印迹免疫测定的一种有用的补充方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验